Latest issueWest Valley hosts a state playoff game; US 395 lanes close near FreyaRead now

Daily Spokane Valley

Health news

Stories from Daily Spokane Valley’s editions, and every report from Spokane Valley’s newsrooms.

Health stories

Written for Daily Spokane Valley’s editions from the reports of two or more newsrooms.

Every edition

Health from local newsrooms

From The Spokesman-Review, gathered by 6AM News, 6AM City’s local news service, in the last two days.

  1. The Spokesman-Review12 hours ago

    J&J Backs Psychedelic-Inspired Biotech in $100 Million Round, on The Spokesman-Review

    Johnson & Johnson is backing a biotech company developing psychedelic-inspired medicines that promise to treat depression without the hallucinations, leading a $100 million financing round as pharmaceutical companies increasingly embrace a once-fringe field. The investment in privately held Delix Therapeutics Inc., through J&J’s venture capital arm, was part of an oversubscribed funding round co-led by SV Health Investors’ Dementia Discovery Fund.